Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

Similar documents
Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

Liver Pathology in the 0bese

New insights into fatty liver disease. Rob Goldin Centre for Pathology, Imperial College

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology

DILI PATHOLOGY. PHILIP KAYE November 2017 BSG Pathology Winter Meeting

Biliary tract diseases of the liver

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

Steatotic liver disease

Slide 7 demonstrates acute pericholangitisis with neutrophils around proliferating bile ducts.

Autoimmune Liver Diseases

How to Approach a Medical Liver Biopsy. 9 th Bryan Warren School of Pathology Pancreatic and Liver Pathology. Sarajevo, 6 th -7 th November 2015

British Liver Transplant Group Pathology meeting September Leeds cases

Drug Induced Liver Disease Role of the Pathologist. Disclosure. DILI can never be excluded. Romil Saxena, MD. Dr. Saxena has nothing to Disclose

AASLD: Boston Rob Goldin

Liver Transplant Pathology a general view

Viral Hepatitis (I) Luigi Terracciano Department of Pathology University Hospital Basel. Basel,

Steatosis/Steatohepatitis

Autoimmune Hepatitis: Histopathology

Role of Liver Biopsy. Role of Liver Biopsy 9/3/2009. Liver Biopsies in Viral Hepatitis: Beyond Grading and Staging

Acute and Chronic Hepatitis John Hart, M.D. University of Chicago Medical Center

PBC/AIH variant/ overlap syndrome vs PBC with hepatitic features?

Case n 1 ( B 92 / 4208 ) Case n 2 ( B 00 / 8249 ) Case n 3 ( B 98 / 8352 )

Disclosures Drug-induced Acute Liver Failure

Enterprise Interest Nothing to declare

Autoimmune hepatitis

Why to biopsy? Indications for liver biopsy in common medical liver diseases- how are they changing?

Diagnostic evaluation of suspected Drug-Induced Liver Injury

CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease

Liver National EQA Scheme. Circulation Q Birmingham, March 15 th 2005

Hepatitis C wi w t i h Ju J dy y W y W a y t a t t

Chronic Biliary Disease. Dr Susan Davies & Dr Bill Griffiths

ACP-BSG meeting The liver in systemic inflammatory disorders. Dr Adrian C Bateman Southampton University Hospitals NHS Trust

Challenges in the Diagnosis of Steatohepatitis

Non-Alcoholic Fatty Liver Disease An Update

Transplant Hepatology

National Liver EQA Scheme. Open meeting, Glasgow March 24th 2004

Special stains in liver pathology

Do Histological Features Inform DILI mechanisms?

in liver pathology? 2014 What s hot

Drug-induced liver injury

AMR in Liver Transplantation: Incidence

-sheet 3. -Waseem Alhaj. Maha Shomaf

2014 CURRENT ISSUES IN PATHOLOGY

Update on Autoimmune Liver Disease. Role of Liver Biopsy in Autoimmune Hepatitis, PBC and PSC

Liver Pathology Symposium - medical livers

Original Article. Significance of Hepatic Steatosis in Chronic Hepatitis B Infection INTRODUCTION

A Systematic Approach to Medical Liver Disease

LIVER DISEASES. Pathology Department, Zhejiang University School of Medicine,

Updates from the AASLD

21/07/2017. Update on Autoimmune Biliary Disease. Changing Role of Liver Biopsy in PBC and PSC. Primary Biliary Cirrhosis Cholangitis

11 th Banff Conference on Allograft Pathology - An Update

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

BSG/ACP annual course Royal College of Pathologists Infections and Inflammations of the Hepato-Biliary System Hepatitis B and D

Nottingham Patterns of liver fibrosis and their clinical significance

Serologic Markers CONVENTIONAL ANTIBODIES ANTIBODIES UNCONVENTIONAL. AIH Type I

Dhanpat Jain Yale University School of Medicine, New Haven, CT

Key Points: Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective. Jenny Heathcote, MD. University of Toronto

Autoimmune Hepatitis in Clinical Practice

Circulation T. Manchester July 5 th 2006

AAIM: GI Workshop Follow Up to Case Studies. Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease

Histology. The pathology of the. bile ducts. pancreas. liver. The lecture in summary. Vt-2006

LIVER TRANSPLANTATION FOR OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASES

Pathology of Fatty Liver Disease

LIVER PATHOLOGY. Thursday 28 th November 2013

Autoimmune Hepatitis. Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern. November 14th, 2018

Non-Cirrhotic Portal Hypertension and Incomplete Septal Cirrhosis. Stefan Hübscher, University of Birmingham, Birmingham B15 2TT, U.K.

Interface hepatitis in PBC: Prognostic marker and therapeutic target

ACCME/Disclosures. The Overlap Syndromes: Do They Exist? Key Points and Questions 4/6/2016. Hans Popper Hepatopathology Society

LIVER SPECIALTY CONFERENCE USCAP Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA

Special stains in liver pathology

Primary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants

PROGRAMME AT A GLANCE

Non alcoholic fatty liver and Non alcoholic Steatohepatitis. By Dr. Seham Seif

Histopathological Causes of Late Liver Allograft Dysfunction: Analysis at a Single Institution

Pitfalls in the diagnosis of well-differentiated hepatocellular lesions

Hangzhou, 15 March Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam

Liver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems

Case #1. Digital Slides 11/6/ year old woman presented with abnormal liver function tests. Liver Biopsy to r/o autoimmune hepatitis

Domenico ALVARO, MD Sapienza, University of Rome, Italy. Congresso Nazionale della Società Italiana di GastroReumatologia, Roma, 25 Giugno 2015.

Case Report of Successful Treatment of Fibrosing Cholestatic Hepatitis C with Sofosbuvir and Ribavirin after Liver Transplantation

HIV/AIDS and the Liver : interlinking challenges

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT

Nonalcoholic Fatty Liver Disease: Definitions, Risk Factors, and Workup

Current Concepts in the Management and Treatment of PBC & PSC

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course

ACCME/Disclosures. PBC and PSC Revisited 4/6/2016. Primary Biliary Cirrhosis Cholangitis (PBC)

Drug- induced Liver Injury. Guruprasad P. Aithal

What s new in liver transplantation? Romil Saxena, MD, FRCPath (UK) Indiana University School of Medicine, Indianapolis

S ince the discovery of hepatitis C, there have been several

Autoimmune Hepatitis: Clinical Overview and Pathological Findings

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Liver and gall bladder curriculum for ST1, presented at Northern block teaching, January 2017.

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Steatosi epatica ed HCV

Relationship between Serum Iron Indices and Hepatic Iron Quantitation in Patients with Fatty Liver Disease

Improving Access to Quality Medical Care Webinar Series

First European NAFLD-NASH Summit European Parliament, Brussels, May 31 st NAFLD/NASH : an expanding burden on liver health

Hepatology for Gastroenterologists and Hematologists. Part Three: Pathology of Chronic Necroinflammatory Liver Disease

Transcription:

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk

Fatty liver disease Is there fatty change? Is there a fatty liver hepatitis? What is the cause of the fatty liver disease? Clinical Liver Disease Volume 2, April 2013, Pages 64 67 (http://onlinelibrary.wiley.com/doi/10.1002/cld.172/full) Clinical Liver Disease Volume 1, September 2012, Pages 108 111 (http://onlinelibrary.wiley.com/doi/10.1002/cld.31/full)

Types of fatty change: Large droplet mesovesicular fatty change

Causes of large droplet fatty change Obesity and Diabetes Mellitus Protein-calorie malnutrition TPN Drugs and toxins (e.g. alcohol, corticosteroids) Metabolic disorders ( e.g. Wilson s Disease) Infections ( e.g. hepatitis C)

Types of fatty change: Small droplet

Causes of small droplet fatty Alcohol change Fatty liver of pregnancy Drugs (e.g. nucleoside analogues) Toxins (e.g. Jamaican vomiting disease) Inborn errors of metabolism (e.g. urea cycle disorders). Reye s syndrome Infections (e.g. Hepatitis A)

Is there fibrosis? Fatty liver disease: More than just fat Is there a fatty liver hepatitis? Ballooning and inflammation

Recognising ballooning (B) Normal hepatocytes, ballooning, grade 0. Cytoplasm is pink and granular and liver cells have sharp angles. (C) Ballooning, grade 1. Hepatocytes have rounded contours with clear reticular cytoplasm. Size is quite similar to that of normal hepatocytes. (D) Ballooning, grade 2. Cells are rounded with clear cytoplasm and twice as large as normal hepatocytes. Hepatology Volume 56, November 2012 Pages 1751 1759

Nuclear vacuolation

Causes of nuclear vacuolation Physiological Insulin resistance Wilson s disease Glycogen storage disease

A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis Gastroenterology, Volume 146, Issue 5, 2014, 1231-1239

Histologic features independently associated with 90-day survival included in the Histologic AHHS. ( A C ) Degree of fibrosis (Masson trichrome staining): portal fibrosis, expansive areas of liver fibrosis, and cirrhosis, respectively. H&E s...

Histologic features independently associated with 90-day survival included in the Histologic AHHS. ( A ) Hepatocellular and canalicular bilirubinostasis ( arrow ). ( B ) Ductular bilirubinostasis ( arrow ). ( C ) Megamitochondria ( arrows ). ( D and E) Mild and severe PMN infiltration, respectively (arrow). H&E stain.

AHHS for Prognostic Stratification of AH Points Stage of fibrosis No fibrosis or portal fibrosis 0 Expansive fibrosis 0 Bridging fibrosis or cirrhosis +3 Bilirubinostasis No 0 Hepatocellular only 0 Canalicular or ductular +1 Canalicular or ductular plus hepatocellular +2 PMN infiltration No/Mild +2 Severe 0 Megamitochondria No megamitochondria +2 Megamitochondria 0 The AHHS categories are as follows: mild, 0 3; intermediate, 4 5; severe, 6 9. Gastroenterology, Volume 146, Issue 5, 2014, 1231-1239

Chronic viral hepatitis Assess disease severity: Grade (necro-inflammation) Stage (fibrosis)? Score (using modified Histological Activity Index / METAVIR) Assess disease progression or response to treatment Modern Pathology 2007; 20: S3

Chronic viral hepatitis Hepatitis related changes: HBV: Ground glass cells HCV: Lymphoid follicles, hepatitic bile duct damage, fatty change HDV: Increased lobular activity Large cell change Clinical Liver Disease Volume 1, April 2012, Pages 32 35 (http://onlinelibrary.wiley.com/doi/10.1002/cld.30/full) Clinical Liver Disease Volume 2, February 2013, Pages 49 51 (http://onlinelibrary.wiley.com/doi/10.1002/cld.139/full)

HBV: Ground glass hepatocytes Orcein

HCV: Lymphoid aggregate/follicle

HCV: Hepatitic bile duct damage

HCV genotype 3: Fatty change

HDV

Something else going on Drug reaction Another virus Fatty liver disease fatty liver hepatitis in 5% of liver biopsies of patients with chronic liver disease Iron overload In patients with HCV: Mod Pathol 2003; 16: 49 stainable iron in 16%, grade 2 and 3 (out of 4) iron in 7%. J Gastroenterol Hepatol 2005; 20: 243

Large cell change (or is it dysplasia?)

Iron overload What is the pattern if iron overload? Grade the degree of iron overload Assess fibrosis? Send tissue for biochemical iron measurement Mod Pathol 2007; 20: S31 S39.

What is the pattern of iron overload? Parenchymal Macrophage

Patterns of iron overload Parenchymal overload gut derived iron. Macrophage iron transfusion derived iron Mixed

Mixed pattern of iron overload: Sickle cell anaemia Ferroportin deficiency

Autoimmune hepatitis Help in making the diagnosis Help in assessing the response to treatment Clinical Liver Disease Volume 3, February 2014, Pages 38 41 (http://onlinelibrary.wiley.com/doi/10.1002/cld.321/full)

Simplified histological criteria for Typical 1. Interface hepatitis the diagnosis of AIH 2. lymphocytic / lympho-plasmacytic infiltrates in portal tracts and extending into the lobule 3. rosetting of liver cells Compatible" a chronic hepatitis with lymphocytic infiltration without all the above features Atypical" for AIH when showing signs of another diagnosis.

Autoimmune Hepatitis

The Overlap Syndromes of Autoimmune Hepatitis Clinical Liver Disease Volume 3, January 2014, Pages 2 5 (http://onlinelibrary.wiley.com/doi/10.1002/cld.294/full)

Drug reaction Any kind of liver disease can be caused by a drug Histological features suggesting a drug reaction: Eosinophils, plasma cells, granulomas, sharply demarcated necrosis, cholestatic hepatitis Clinical Liver Disease Volume 4, Issue 1, July 2014, Pages 12 16 (http://onlinelibrary.wiley.com/doi/10.1002/cld.371/full)

Injury Patterns of Selected Drugs in Common Use Drug Paracetamol Amiodarone and fibrosis Amoxicillin-clavulanate Anabolic steroids Azithromycin Diclofenac Isoniazid Methotrexate Minocycline Nitrofurantoin Oxaliplatin Pattern of Injury Zone 3 necrosis (with little additional inflammation) Steatohepatitis-like, with numerous Mallory-Denk bodies Cholestatic hepatitis (with prominent duct injury) Acute cholestasis to cholestatic hepatitis with little duct injury Variable: Hepatitis with or without cholestasis Zone 3 necrosis with lymphocytic inflammation Acute or chronic hepatitis Steatosis and fibrosis, sometimes steatohepatitis-like Acute or chronic hepatitis Acute or chronic hepatitis Hepatoportal sclerosis, sinusoidal dilation, nodular regenerative hyperplasia

Drug reaction

Drug reaction

Drug reaction

Histological predictors of severity in drug-induced liver disease. More severe disease associated with: 1. necrosis 2. fibrosis stage 3. microvesicular steatosis 4. cholangiolar cholestasis 5. bile duct damage Milder disease associated with: 1. granulomas 2. increased eosinophils

http://livertox.nih.gov/

Biliary tract disease

Biliary tract disease: Orcein stain

Biliary tract disease: CK7

Causes of Disappearing Bile Ducts PBC* (and its variants) PSC (and its variants) Drugs and Toxins Chronic transplant rejection Graft Vs. Host Hodgkin s Disease, Histiocytosis X Sarcoid Paucity of interlobular bile ducts HIV Idiopathic

Primary Biliary Cholangitits = the name for Primary Biliary Cirrhosis

Vascular Disease: Non-cirrhotic portal hypertension

Vascular Disease: Non-cirrhotic portal hypertension

Causes of Nodular Regenerative Hyperplasia Connective tissue disorders Myeloproliferative disorders Chronic vascular congestion Drugs e.g. steroids, anticancer drugs, anticonvulsants, immunosuppressive agents Clinical Liver Disease, Volume 6, October 2015, Pages 103 106 (http://onlinelibrary.wiley.com/doi/10.1002/cld.505/full)

Discrepancy rates in liver biopsy fibrosis staging reporting recognising and interpreting bile duct disorders misdiagnoses of autoimmune hepatitis J Clin Pathol 2014;67:825-827 Histopathology. 2016 Jan 30. doi: 10.1111/his.12940

What clinical information does the pathologist need? A decent clinical history!

Clinical information Look at the biopsy and write the description without knowing any clinical information Only write the conclusion when you have the information

Example of not very useful clinical information Liver biopsy Abnormal LFTs Complex medical history

Recent request form

http://onlinelibrary.wiley.com/journal/10.1002/(issn)2046-2484